Transferrin receptor in tissue and serum: Updated clinical significance of soluble receptor

International Journal of Hematology

Volumn 76, Issue 3, 2002, Pages 213-218

  Kohgo, Yutaka ^a   Torimoto, Yoshihiro ^a   Kato, Junji ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Anemia of chronic disorder; Cellular iron uptake; Iron responsive element; Soluble transferrin receptor; Transferrin receptor

Indexed keywords

CD71 ANTIGEN; IRON; TRANSFERRIN RECEPTOR; TRANSFERRIN RECEPTOR 2; FERRITIN;

ARTICLE; CHRONIC DISEASE; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; PROTEIN SYNTHESIS; TISSUE; TRANSFERRIN BLOOD LEVEL; BIOSYNTHESIS; BLOOD; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; RNA PROCESSING;

ANEMIA, IRON-DEFICIENCY; CHRONIC DISEASE; ERYTHROPOIESIS; FERRITINS; GENE EXPRESSION REGULATION; HUMANS; IRON; PROGNOSIS; RECEPTORS, TRANSFERRIN; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EID: 0036780241     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982790     Document Type: Article

References (77)

1. Kawabata H, Yang R, Hirama T, et al. Molecular cloning of transferrin receptor 2: a new member of the transferrin receptor-like family. J Biol Chem. 1999;274:20826-20832.
2. Shih YJ, Bayness RD, Hudson BG, Flowers CH, Skikne BS, Cook JD. Serum transferrin receptor is a truncated form of tissue receptor. J Biol Chem. 1990;265:19077-19081.
3. Kohgo Y, Nishisato T, Kondo H, Tsushima N, Niitsu Y, Usushizaki I. Circulating transferrin receptor in human serum. Br J Haematol. 1986;64:277-281.
4. Allen J, Backstrom KR, Cooper JA, et al. Measurement of soluble transferrin receptor in serum of healthy adults. Clin Chem. 1998;44:35-39.
5. Jandl JH, Katz JH. The plasma-to-cell cycle of transferrin in iron utilization. J Clin Invest. 1963;42:314.
6. Uchida T. Overview of iron metabolism. Int J Hematol. 1995;62:193-202.
7. Dautry-Varsat A, Chechanover A, Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci U S A. 1983;80:2258-2262.
8. Levy JE, Jin O, Fujiwara Y, Kuo F, Andrews NC. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet. 1999;21:396-399.
9. Johnston RM. The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosome as a mechanism for shedding membrane proteins. Biochem Cell Biol. 1992;70:179-190.
10. Shintani N, Kohgo Y, Kato J, et al. Expression and extracellular release of transferrin receptor during peripheral erythroid progenitor cell differentiation in liquid culture. Blood. 1994;83:1209-1215.
11. Jing SQ, Trowbridge IS. Identification of the intermolecular disulfide bonds of the human transferrin receptor and its lipid-attachment site. EMBO J. 1987;6:327-331.
12. Iacopetta BJ, Rotehnberger S, Kuhn LC. A role for the cytoplasmic domain in transferrin receptor sorting and coated pit formation during endocytosis. Cell. 1988;12:485-489.
13. Gross CN, Irrinki A, Feder JN, Enns CA. Co-trafficking of HFE, a nonclassical major histocompatibility complex class I protein, with the transferrin receptor implied a role in intracellular iron. J Biol Chem. 1998;273:22068-22074.
14. Roetto A, Totaro A, Piperno A, et al. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3. Blood. 2001;97:2555-2560.
15. Camaschella C, Roetto A, Cali A, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000;25:14-15.
16. West AP, Bennett M, Sellers VM, Andrews NC, Enns CA, Bjorkman PJ. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem. 2000;276:38135-38138.
17. Melefors O, Hentze MW. Iron regulatory factor: the conductor of cellular iron regulation. Blood Rev. 1993;7:251-258.
18. Casey JL, Hentze MW, Koeller DM, et al. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science. 1988;240:924-928.
19. Mullner EW, Neupert B, Kuhn LC. A specific mRNA binding factor regulates the iron-dependent stability of cytoplasmic transferrin receptor mRNA. Cell. 1989;58:373-382.
20. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood. 1997;89:1-25.
21. Pantopoulos K, Hentze MW. Rapid responses to oxidative stress mediated by iron regulatory protein. EMBO J. 1995;14:2917-2924.
22. Weiss G, Houston T, Kastner S, Johrer K, Grunewald K, Brock JH. Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood. 1997;89:680-687.
23. Hirayama M, Kohgo Y, Kondo H, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokine in the hepatic deposition of iron. Hepatology. 1993;18:874-870.
24. Toth I, Yuan L, Rogers JT, Boyce H, Bridges KR. Hypoxia alters iron-regulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J Biol Chem. 1999;274:4467-4473.
25. Lok CN, Ponka P. Identification of an erythroid active element in the transferrin receptor gene. J Biol Chem. 2000;275:24185-24190.
26. Flemming RE, Migas MC, Holden CC, et al. Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000;97:2214-2219.
27. Kawabata H, Nakamaki T, Ikonomi P, Smith RD, Germain RS, Koefler HP. Expression of transferrin receptor 2 in normal and neoplastic cells. Blood. 2001;98:2714-2719.
28. Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell. 1998;93:111-123.
29. Bennett MJ, Lebron JA, Bjorkman PJ. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature. 2000;403:46-53.
30. Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci U S A. 1998;95:1472-1477.
31. Ikuta K, Fujimoto Y, Suzuki Y, et al. Overexpression of hemochromatosis protein, HFE, alters transferrin recycling process in human hepatoma cells. Biochim Biophys Acta. 2000;1496:221-231.
32. West AP Jr, Giannetti AM, Herr AB, et al. Mutation analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. J Mol Biol. 2001;313:385-397.
33. Canonne-Hergaux F, Zhang AS, Ponka P, Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) 1 in red blood cells of normal and anemic mk/mk mice. Blood. 2001;98:3823-3830.
34. Kohgo Y, Niitsu Y, Nishisato T, et al. Externalization of transferring receptor in established cell lines. Cell Biol Int Rep. 1987;11:871-879.
35. Rutledge EA, Green FA, Enns CA. Generation of the soluble transferrin receptor requires cycling through an endosomal compartment. J Biol Chem. 1994;269:31864-31868.
36. Bayness RD, Shih YJ, Hudson BG, Cook JD. Production of the serum form of the transferrin receptor by a cell membrane-associated serine protease. Proc Soc Exp Biol Med. 1993;204:65-69.
37. Kato J, Kobune M, Kohgo Y, et al. Ratio of transferrin (TF) to Tf-receptor complex in circulation differs depending on Tf iron saturation. Clin Chem. 2002;48:181-183.
38. Kohgo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood. 1987;70:1955-1958.
39. Cook JD, Skikne BS, Baynes RD. Serum transferrin receptor. Annu Rev Med 1993;44:63-74.
40. Skikne BS. Circulating transferrin receptor assay: coming of age. Clin Chem. 1998;44:7-9.
41. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 1990;75:1870-1876.
42. Huebers HA, Beguin Y, Pootrakul P, Einspahr D, Finch CA. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood. 1990;75:102-107.
43. R'zik S, Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp Hematol. 2001;29:677-685.
44. Choi JW, Pai SH, Im MW, Kim SK. Serum transferrin receptor concentrations with age. Clin Chem. 1999;45:1562-1563.
45. Cooper MJ, Zlotkin SH. Day-to-day variation of transferrin receptor and ferritin in healthy men and women. Am J Clin Nutr. 1996;64:738-742.
46. Virtanen MA, Viinikka LU, Virtanen MK, et al. Higher concentrations of serum transferrin receptor in children than in adults. Am J Clin Nutr. 1999;69:256-260.
47. Kohgo Y, Niitsu Y, Nishisato T, et al. Immunoreactive transferrin receptor in sera of pregnant women. Placenta. 1988;9:523-531.
48. Choi JW, Pai SH. Change in erythropoiesis with gestational age during pregnancy. Ann Hematol. 2001;80:26-31.
49. Akesson A, Bjellerup P, Ferglund M, Bremme K, Vahter M. Serum transferrin receptor: a specific marker of iron deficiency in pregnancy. Am J Clin Nutr. 1998;68:1241-1246.
50. Zhu YI, Haas JD. Response of serum transferrin receptor to iron supplementation in iron-depleted nonanemic women. Am J Clin Nutr. 1998;67:271-275.
51. Khumalo H, Gomo ZAR, Moyo VM, et al. Serum transferrin receptors are decreased in the presence of iron overload. Clin Chem. 1998;44:40-44.
52. Gimferrer E, Ubeda J, Royo MT, et al. Serum transferrin receptor levels in different stages of iron deficiency. Blood. 1997;90:1332-1334.
53. Suominen P, Punnonen K, Rajamaki A, Irjata K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 1998;92:2934-2939.
54. Kohgo Y, Niitsu Y, Nishisato T, et al. Quantitation and characterization of serum transferrin receptor in patients with anemias and polycythemias. Jpn J Med. 1988;27:64-70.
55. Verhoer H, West CE, Ndeto P, Burema J, Beguin Y, Kok FJ. Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. Am J Clin Nutr. 2001;74:767-775.
56. Bessho M, Hirashima K, Asano S, et al. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a multicenter randomized controlled study. Muticenter Study Group. Eur J Haematol. 1997;58:265-272.
57. Testa U, Rutella S, Martucci R, et al. Autologous stem cell transplantation: evaluation of erythropoietic reconstitution by highly fluorescent reticulocyte counts, erythropoietin, soluble transferrin receptors, ferritin, TIBC and iron dosages. Br J Haematol. 1997;96:762-775.
58. Beguin Y. Prediction of response to optimize outcome of treatment with erythropoietin. Semin Oncol. 1998;25(suppl 7):27-34.
59. Chen C-H, Cheng C-H, Cheng T-C, Shu K-H, Wu M-N, Lian J-D. Serum transferrin receptor is a good index of erythropoietin treatment in ESRD. Acta Nephrol. 1998;12:6-11.
60. Beguin Y, Loo M, R'Zik S, et al. prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood. 1993;82:2010-2016.
61. Ahluwalia N, Skikne BS, Savin V, Chonko A. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure. Am J Kidney Dis. 1997;30:532-541.
62. Song JS, Park W, Bae SK, et al. The usefulness of serum transferrin receptor (sTfR) and ferritin in anemic patients with rheumatoid arthritis (RA) compared with bone marrow storage iron and other tests for anemia. Rheumatol Int. 2001;21:24-29.
63. Baumann Kurer S, Seifert B, Michel B, Ruegg R, Fehr J. Prediction of iron deficiency in chronic inflammatory rheumatic disease anaemia. Br J Haematol. 1995;91:820-826.
64. Punnonen K, Irjala K, Rajamaki. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89:1052-1057.
65. Malope BI, MacPhail P, Alberts M, Hiss DC. The ratio of serum transferrin receptor and serum ferritin in the diagnosis of iron status. Br J Haematol. 2001;115:84-89.
66. van Tellingen A, Kuenen JC, de Kieviet W, van Tinteren H, Kooi ML, Vasmel WL. Iron deficiency anemia in hospitalized patients: value of various laboratory parameters: differentiation between IDA and ACD. Neth J Med. 2001;59:270-279.
67. Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol. 1999;70:7-12.
68. Cartwright GE. The anemia of chronic disorders. Semin Hematol. 1966;3:351-368.
69. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest. 1986;61:319-322.
70. Rogers JT, Bridges KR, Durmowicz GP, Glass J, Auron PE, Munro HN. Translational control during the acute phase response: ferritin synthesis in response to interleukin 1. J Biol Chem. 1990;265:14572-14578.
71. Kobune M, Kohgo Y, Kato J, Miyazaki E, Niitsu Y. Interleukin-6 enhances hepatic transferrin uptake and ferritin expression in rats. Hepatology. 1994;19:1468-1475.
72. Weiss G, Bogdan C, Hentze MW. Pathways for the regulation of macrophage iron metabolism by the anti-inflammatory cytokines IL-4 and IL-13. J Immunol. 1997;158:420-425.
73. Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. Proc Natl Acad Sci U S A. 1996;93:8175-8182.
74. Suominen P, Punnonen K, Rajamaki A, Irjala K. Evaluation of new immunoenzymometric assay for measuring soluble transferrin receptor to detect iron deficiency in anemic patients. Clin Chem. 1997;43:1641-1646.
75. Coenen JL, van Dieijen-Visser MP, van Pelt J, et al. Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease. Clin Chem. 1991;37:560-563.
76. Torimoto Y, Kohgo Y. Transferrin receptor in erythropoiesis [in Japanese]. Rinsho Ketsueki. 2000;41:554-558.
77. Kohgo Y. Disorders of iron metabolism involving erythropoiesis: molecular mechanism of gut-liver-bone marrow axis [in Japanese]. Rinsho Ketsueki. 2001;42:397-402.